As a graduate of the post-doctoral fellowship in cancer imaging at the Vanderbilt University Institute of Imaging Science, Dr. Niermann is currently conducting phase I clinical research for radiosensitizing biologic agents administered concurrently with radiation therapy. His research interests include using novel imaging techniques to quantify treatment response.

Education

Master of Science in Clinical Investigation – Vanderbilt University
Post-Doctoral Fellowship in Cancer Imaging – Vanderbilt University Institute of Imaging Science